Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Asacol Dosing Study for Active Ulcerative Colitis

This study has been completed.
Sponsor:
Collaborator:
Procter and Gamble
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00194818
First received: September 15, 2005
Last updated: February 13, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)